Skip Nav Destination
Issues
Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line
J Immunol (1985) 135 (3): 2228.
Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
J Immunol (1985) 135 (3): 2033–2039.
Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
J Immunol (1985) 135 (3): 2192–2198.
Structure and expression of two porcine genomic clones encoding class I MHC antigens.
J Immunol (1985) 135 (3): 2167–2175.
Isolation and characterization of novel suppressor T cell clones from murine fetal thymus.
J Immunol (1985) 135 (3): 1582–1588.
TNP-specific Lyt-2+ cytolytic T cell clones preferentially respond to TNP-conjugated epidermal cells.
J Immunol (1985) 135 (3): 1558–1563.
Commentary on the genetic basis for control of I-J determinants.
J Immunol (1985) 135 (3): 1543–1547.
Antiproliferative monoclonal antibodies: detection and initial characterization.
J Immunol (1985) 135 (3): 1987–1997.
Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
J Immunol (1985) 135 (3): 2015–2019.
Carbohydrate determinants associated with carcinoembryonic antigen (CEA).
J Immunol (1985) 135 (3): 1911–1913.
Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.
J Immunol (1985) 135 (3): 1813–1818.
Human T cell antigen expression during the early stages of fetal thymic maturation.
J Immunol (1985) 135 (3): 1752–1759.
Functional integrity of cytokineplasts: specific chemotactic and capping responses.
J Immunol (1985) 135 (3): 2090–2094.
Induction of antibody responses to influenza virus in human lymphocyte cultures. I. Role of interleukin 2.
J Immunol (1985) 135 (3): 2128–2133.
T cell locomotion in the tumor microenvironment. I. A collagen-matrix assay.
J Immunol (1985) 135 (3): 2220–2227.
Biosynthesis and maturation of the Lyt-2/3 molecular complex in mouse thymocytes.
J Immunol (1985) 135 (3): 1937–1944.
Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
J Immunol (1985) 135 (3): 1786–1791.
Influence of antibody isotype on passive serotherapy of lymphoma.
J Immunol (1985) 135 (3): 2183–2186.
Interleukin 2 receptor dysfunction in mice undergoing a graft-vs-host reaction.
J Immunol (1985) 135 (3): 1846–1850.
Characterization and partial purification of a specific interleukin 2 inhibitor.
J Immunol (1985) 135 (3): 1834–1839.
Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
J Immunol (1985) 135 (3): 1826–1833.
Conditions required for expression of membrane IL 1 on B cells.
J Immunol (1985) 135 (3): 1548–1550.
The distribution of the Qa-2 alloantigen on functional T lymphocytes.
J Immunol (1985) 135 (3): 1632–1636.
Mechanism of priming of human neutrophils by a soluble lymphoblastoid cell factor.
J Immunol (1985) 135 (3): 2074–2083.
A histamine-releasing factor from activated human mononuclear cells.
J Immunol (1985) 135 (3): 2027–2032.
Association between the Ro and La antigenic determinants: immunodiffusion analysis of human spleen extract.
J Immunol (1985) 135 (3): 1707–1713.
Immune response to nucleic acid antigens and native DNA by human peripheral blood lymphocytes in vitro.
J Immunol (1985) 135 (3): 1772–1777.
Defining cytolytic T lymphocyte recognition of chemically modified self. I. Response to trinitrophenyl-H-2Kk.
J Immunol (1985) 135 (3): 1564–1572.
Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
J Immunol (1985) 135 (3): 2063–2068.
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
G D Ross; W J Yount; M J Walport; J B Winfield; C J Parker; C R Fuller; R P Taylor; B L Myones; P J Lachmann
J Immunol (1985) 135 (3): 2005–2014.
Lymphokine-activated and natural killer cell activity in human intestinal mucosa.
J Immunol (1985) 135 (3): 1731–1738.
Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
J Immunol (1985) 135 (3): 1719–1723.
Molecular associations of class II MHC antigens in mitogen-stimulated B cells.
J Immunol (1985) 135 (3): 1668–1673.
Genetic and biological characterization of a T suppressor cell induced by anti-idiotypic antibody.
J Immunol (1985) 135 (3): 1589–1597.
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production
J Immunol (1985) 135 (3): 2228.
Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.
J Immunol (1985) 135 (3): 1760–1765.
Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
J Immunol (1985) 135 (3): 1900–1905.
Lymphokine-activated killer cells are generated before classical cytotoxic T lymphocytes after bone marrow transplantation in mice.
J Immunol (1985) 135 (3): 1702–1706.
Preferential generation of human T cell hybrids with a tetraploid fusion partner.
J Immunol (1985) 135 (3): 1792–1799.
Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
J Immunol (1985) 135 (3): 1766–1771.
Strong suppression by monocytes of T cell mitogenesis in chicken peripheral blood leukocytes.
J Immunol (1985) 135 (3): 1652–1660.
Demyelination induced by Theiler's virus: influence of the H-2 haplotype.
J Immunol (1985) 135 (3): 2145–2148.
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement
Advertisement